Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: A randomized, pragmatic study

Current Medical Research and Opinion

Volumn 28, Issue 8, 2012, Pages 1289-1296

  Aravind, S R ^a   Ismail, Shaiful Bahari ^b   Balamurugan, R ^c   Gupta, Jugal Bihari ^d   Wadhwa, Tarun ^e   Loh, Sze Min ^e   Suryawanshi, Shailaja ^e   Davies, Michael J ^e   Girman, Cynthia J ^e   Katzeff, Harvey L ^e   Radican, Larry ^e   Engel, Samuel S ^e   Wolthers, Troels ^e  

^a Diacon Hospital   (India)

^b HOSPITAL UNIVERSITI SAINS MALAYSIA   (Malaysia)

^c Kovai Diabetes Speciality Centre and Hospital   (India)

^d S R Kalla Memorial Hospital   (India)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Diabetes; DPP 4 inhibitors; Fasting; Hypoglycemia; Ramadan; Sulfonylurea

Indexed keywords

GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; HEMOGLOBIN A1C; METFORMIN; SITAGLIPTIN; SULFONYLUREA;

ADULT; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; FOLLOW UP; GASTRIC HYPERACIDITY; GASTRITIS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHLORHYDRIA; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; INDIA; MAJOR CLINICAL STUDY; MALAYSIA; MOSLEM; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SCREENING; SIDE EFFECT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INDIA; ISLAM; MALAYSIA; MALE; MIDDLE AGED; PYRAZINES; SULFONYLUREA COMPOUNDS; TRIAZOLES; YOUNG ADULT;

EID: 84864550799     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2012.707119     Document Type: Article

References (14)

1. Jaleel MA, Raza SA, Fathima FN, et al. Ramadan and diabetes: As-Saum (The fasting). Indian J Endocrinol Metab 2011;15:268-73
2. Salti I, Benard E, Detournay B, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 2004;27:2306-11
3. Al Arouj M, Assaad-Khalil S, Buse J, et al. Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care 2010;33:1895-902
4. Hassanein M. Diabetes and Ramadan: how to achieve a safer fast for Muslims with diabetes. Brit J Diabetes Vasc Dis 2010;10:246-50
5. Aravind SR, Tayeb K, Ismail SB, et al. Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: A five-country observational study. Curr Med Res Opin 2011;27:1237-42
6. Richard KR, Shelburne JS, Kirk JK. Tolerability of dipeptidyl peptidase-4 inhibitors: A review. Clin Ther 2011;33:1609-29
7. Al Sifri S, Basiounny A, Echtay A, et al. The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: A randomised trial. Int J Clin Pract 2011;65:1132-40
8. Shete AVV. Real life experience of usage of vildagliptin versus sulfonylurea therapy in fasting patients with type 2 diabetes during Ramadan: An Indian experience (abstract). Diabetologia 2011;54(Suppl 1):S342-3
9. Devendra D, Gohel B, Bravis V, et al. Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan. Int J Clin Pract 2009;63:1446-50
10. Hassanein M, Hanif W, Malik W, et al. Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study. Curr Med Res Opin 2011;27:1367-74
11. Baetta R, Corsini A. Pharmacology of dipeptidyl peptidase-4 inhibitors: similarities and differences. Drugs 2011;71:1441-67
12. Bell DS. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy. Clin Ther 2004;26:1714-27
13. Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes: scientific review. JAMA 2002;287:360-72
14. Bravis V, Hui E, Salih S, et al. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan. Diabet Med 2010;27:327-31